Influence of processing variables on the properties of gelatin microspheres prepared by the emulsification solvent extraction technique

Journal of Microencapsulation

Volumn 15, Issue 3, 1998, Pages 273-281

  Ugwoke, M I ^a   Kinget, R ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

Author keywords

Emulsification; Gelatin; Microencapsulation; Microspheres; Solvent extraction

Indexed keywords

GELATIN; MICROSPHERE; RIBOFLAVIN; SURFACTANT;

ARTICLE; EMULSION; EXTRACTION; MICROENCAPSULATION; PARTICLE SIZE; TECHNIQUE; VISCOSITY;

EID: 0031945425     PISSN: 02652048     EISSN: None     Source Type: Journal    
DOI: 10.3109/02652049809006857     Document Type: Article

References (26)

1. CHIAO, C. S. L., and PRICE, J. C., 1989, Modification of gelatin beadlets for zero-order sustained release. Pharmaceutical Research, 6, 517-520.
2. FORNI, F., VANDELLI, M. A., and CAMERONI, R., 1992, Influence of drug loading level on drug release and dynamic swelling of crosslinked gelatin microspheres. Journal of Microencapsulation, 9, 29-39.
3. GIUNCHEDI, P., TORRE, M. L., MAGGI, L., CONTI, B., and CONTE, U., 1995, Cellulose acetate trimellitate microspheres containing NSAIDs. Drug Development and Industrial Pharmacy, 21, 315-330.
4. HASHIDA, M., MURANISHI, S., SEZAKI, H., TANIGAWA, N., SATOMURA, K., and HIKASA, Y., 1979, Increased lymphatic delivery of bleomycin by microsphere in oil emulsion and its effect on lymph node metastasis. International Journal of Pharmaceutics, 2, 245-256.
5. JEYANTHI, R., and RAO, K. P., 1987, Preparation of gelatin microspheres of bleomycin. International Journal of Phamaceutics, 35, 177-179.
6. KRAMER, P. A., 1974, Albumin microspheres as vehicle for achieving specificity in drug delivery. Journal of Pharmaceutical Sciences, 63, 1646-1647.
7. LEUCUTA, S. E., 1989, The kinetics of in vitro release and the pharmacokinetics of miotic response in rabbits of gelatin and albumin microspheres with pilocarpine. International Journal of Phamaceutics, 54, 71-78.
8. LEUCUTA, S. E., 1990, Controlled release of nifedipine from gelatin microspheres and microcapsules: in vitro kinetics and pharmacokinetics in man. Journal of Microencapsulation, 7, 209-217.
9. LONGER, M. A., and ROBINSON, J. R., 1986, Fundamental aspects of bioadhesion. Pharmacy International, 6, 114-117.
10. LUZZI, L. A., and GERRAUGHTY, R. J., 1967, Effect of additives and formulation techniques on controlled release of drugs from microcapsules. Journal of Pharmaceutical Sciences, 9, 1174-1177.
11. MADAN, P. L., 1981, Clofibrate microcapsules II; effect of wall thickness on release characteristics. Journal of Pharmaceutical Sciences, 70, 430-433.
12. MADAN, P. L., JAM, R. K., and BARTILUCCI, A. J., 1978, New method of preparing gelatin microcapsules of soluble pharmaceuticals. Journal of Pharmaceutical Sciences, 63, 409-411.
13. MADAN, P. L., LUZZI, L. A., and PRICE, C. J., 1974, Microencapsulation of a waxy solid: wall thickness and surface appearance studies. Journal of Pharmaceutical Sciences, 63, 280-284.
14. MORITERA, T., OGURA, Y., HONDA, Y., WADA, R., HYON, S., and IKADA, Y., 1991, Microspheres of biodegradable polymers as a drug-delivery system in the vitreous. Investigative Ophthalmology and Visual Sciences, 62, 1785-1790.
15. NARAYANI, R., and RAO, K. P., 1994, Controlled release of anti-cancer drug, methotrexate, from biodegradable gelatin microspheres. Journal of Microencapsulation, 11, 69-77.
16. NASTRUZZI, C., PASTESINI, C., CORTESI, R., ESPOSITO, E., GAMBARI, R., and MENEGATTI, E., 1994, Production and in vitro evaluation of gelatin microspheres containing an antitumour tetra-amidine. Journal of Microencapsulation, 9, 309-316.
17. RATCLIFFE, J. L., HUNNEYBALL, I. M., SMITH, A., WILSON, C. G., and DAVIS, S. S., 1984, Preparation and evaluation of biodegradable polymeric systems for intra-articular delivery of drugs. Journal of Pharmacy and Pharmacology, 36, 431-436.
18. RAYMOND, G., DEGENNARO, M., and MIKEAL, R., 1990, Preparation of gelatin:phenytoin sodium microspheres: an in vitro and in vivo evaluation. Drug Development and Industrial Pharmacy, 16, 1025-1051.
19. TABATA, Y., and IKADA, Y., 1989, Synthesis of gelatin microspheres containing interferon. Pharmaceutical Research, 6, 422-427.
20. TANAKA, N., TAKINO, S., and UTSUMI, I., 1963, A new oral gelatinized sustained-release dosage form. Journal of Pharmaceutical Sciences, 52, 664-667.
21. VANDELLI, M. A., FORM, F., IANNUCCELLI, V., and CAMERONI, R., 1991a, The concentration of the cross-linking agent as a tool for the control of release and swelling properties of gelatin microspheres. Journal de Pharmacie de Belgique, 46, 381-388.
22. VANDELLI, M. A., FORM, F. IANNUCCELLI, V., and CAMERONI, R., 1991b, The effect of crosslinking time period upon the drug release and dynamic swelling of gelatin microspheres. Pharmazie, 46, 866-869.
23. VIVIEN, X., BURI, P., BALANT, L., and LACROIX, S., 1994, Nasal asorption of metoclopramide administered to man. European Journal of Pharmacy and Biopharmaceutics, 40, 228-231.
24. VYAS, S. P., BHATNAGAR, S., GOIGOI, P. J., and JAIN, N. K., 1991, Preparation and characterization of HSA-propranolol microspheres for nasal administration. International Journal of Pharmaceutics, 69, 5-12.
25. WAN, L. S. C., HENG, P. W. S., and CHAN, L. W., 1992, Drug encapsulation in alginate microspheres by emulsification. Journal of Microencapsulation, 9, 309-316.
26. YOSHIOKA, T., HASHIDA, M., MURANISHI, S., and SEZAKI, H., 1981, Specific delivery of mitomycin to the liver, spleen and lung: nano- and microspherical carriers of gelatin. International Journal of Pharmaceutics, 81, 131-141.